Previous 10 | Next 10 |
TORONTO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenue results for the three months ended December 31, 2021. ...
Today, we revisit Venus Concept, a small medical device manufacturer and marketer for the first time since early this year. The company continues to deliver significant revenue growth despite the lingering effects of the pandemic and supply chain challlenges. A full investment ana...
Gainers: Society Pass (NASDAQ:SOPA) +237%. Bluerock Residential Growth (NYSE:BRG) +71%. Can-Fite (NYSE:CANF) +59%. AeroClean (NASDAQ:AERC) +58%. Galera Therapeutics (NASDAQ:GRTX) +38%. Verso (NYSE:VRS) +35%. Roivant (NASDAQ:ROIV) +26%. Venus (NASDAQ:VERO) +25%. BioCardia (NASDAQ:BCDA) +1...
Whether you’re looking for a Santa Claus Rally or trying to find some tax-loss harvesting opportunities, omicron fears have slapped the market in the face to start the short holiday week. Over the weekend, concerns began to grow thanks to commentary from the scientific community. The...
Can-Fite BioPharma (NYSE:CANF) +71% liver cancer patient treated with can-Fite’s Namodenoson clears all cancer lesions under open label extension of phase II study. Society Pass Incorporated (NASDAQ:SOPA) +35% on being added to the Russell 2000 Index. Verso (NYSE:VRS) +3...
Venus Concept (NASDAQ:VERO) trades 1.6% higher premarket after it closed a non-brokered private placement of shares and preferred nonvoting shares; post placement, 9.8M shares and 3.8M preferred non-voting shares were issued at $1.25/share for gross proceeds of ~$17M....
TORONTO, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has completed a non-brokered private placement (the “Private Placement...
Venus Concept Inc. (VERO) Q3 2021 Earnings Conference Call November 12, 2021 08:00 ET Company Participants Dom Serafino - Chief Executive Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Marie Thibault - BTIG Suraj Kalia - O...
Venus Concept (NASDAQ:VERO): Q3 GAAP EPS of -$0.18 misses by $0.06. Revenue of $24.6M (+19.0% Y/Y) misses by $1.83M. Press Release For further details see: Venus Concept EPS misses by $0.06, misses on revenue
TORONTO, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2021. Third Quar...
News, Short Squeeze, Breakout and More Instantly...
TORONTO, July 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2024 financial results will be released before the market o...
TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announces the successful completion of its NEXThetics events held across several major cities in North America. NEXThetics events bring to...
TORONTO, June 17, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has entered a new strategic resurfacing and skin tightening device supply arrangement with Skin Laundry Holdings, ...